Navigation Links
KPMG Optimistic About Indian Pharma’s Growt

The Indian pharma industry is well positioned to capture much of the $65 billion new business expected to open up globally next year, a new KPMG study reveals//.

"The Indian pharma industry is currently worth $6 billion - in a global industry worth $650 billion - and is growing at 10 percent, compared to the global industry rate of seven percent," said John Morris, global head of KPMG's pharmaceuticals practice, commenting on the new study.

"The generics business remains at the heart of everything India does well and so it should, considering that India accounts for 22 percent of the global generics market."

"Bearing in mind that $65 billion of prescription medicines in Europe and the US are to lose their patents in 2007-08, India is ideally positioned to sweep up much of that new business."

Morris however pointed out that opportunity now exists for India to become so much more than just a generics player and shape up as a developer of new drugs.

Much of the impetus behind India's fresh challenge for a greater share of the global industry is driven by last year's introduction of product patents.

For the previous 25 years, patents were only granted on processes - a decision which saw many MNCs abandon the subcontinent, but which resulted in India becoming a leading player in the market for generic medicines.

The expansion of India's patent system to cover products as well as processes has already started to bring the MNCs back into the fold, the report points out.

There was never much point in Indian manufacturers spending too much on research and development of their own when their new product discoveries could not be patent-protected.

With patent protection in place and foreign investors eagerly eyeing India's wealth of human resources, and its massive domestic market, significant growth opportunities abound for Indian companies.

The patent change regime in 2007-08
'"/>




Page: 1 2

Related medicine news :

1. Scientist Optimistic In Breakthrough For Causes Of Neurodegenerative Diseases
2. Doctors Optimistic on Separating the Conjoined US Twins
3. Experts Are Optimistic Of Making Waterborne Infectious Diseases A Thing Of Past
4. WHOs New Chief Very Optimistic
5. Breast Cancer Survivors Worry About Infertility
6. Breast Cancer Survivors Worry About Infertility
7. Improving Lighting Could Bring About A Change In Alzheimers Patients
8. Poll Finds Many Americans Misinformed About Cancer
9. Poll Finds Many Americans Misinformed About Cancer
10. Study Warns About The Use Of Popular Asthma Drug To Stop Childrens Coughs
11. Scientists Develop New Technology To Find About Human Ancestors’ Teet
Post Your Comments:
(Date:10/13/2008)...wire/ -- The National Coalition for,Quality Colore...cerns over,the National CT Colonography Study publ...edicine. The evidence must be closely evaluated, a... is not without significant,potential risks. The N...y,remains the "Gold Standard" for colorectal cance...
(Date:10/13/2008)...-USNewswire/ -- The 2008 NCPA Digest,sponsored by...10th Annual,Convention. The Digest has been publis...st comprehensive portrait of the financial state o... calendar year. Last year,s,Digest provided an ins...,drug program had played a leading role in reducin...
(Date:10/13/2008)... after weekly doses up to 3 times recommended amou...-- Existing guidelines for treating vitamin D defi...w and put patients at high risk for bone loss and ...ohns Hopkins Children,s Center looked at 262 child...ldren were vitamin D-deficient, and most of them r...
(Date:10/13/2008)...bs.com and numerous newspaper affiliates have anno.... AtlantaJobs.com is the newest online job board ...kers in the metro Atlanta area. , ...AtlantaJobs.com and numerous newspaper affiliates...s.com is the newest online job board dedicated to...
Breaking Medicine News(10 mins):Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 3Health News:Positive Picture of Independent Community Pharmacies Emerges With Release of 2008 NCPA Digest, Sponsored by Cardinal Health 2Health News:Positive Picture of Independent Community Pharmacies Emerges With Release of 2008 NCPA Digest, Sponsored by Cardinal Health 3Health News:Vitamin D Guidelines Too Low for Cystic Fibrosis Kids 2Health News:Atlanta Area Job Board Launches New Local Job Board to Connect Local Employers and Jobseekers 2
...roversial licensing scheme. According to it, the p... will be permitted to describe the ailments they c...meopathic remedies into the area of licensed medic...gned. However, doctors and scientists believe that...
...l Centre have found that a glass of orange juice e...ones than any other citrus juices like lemonade. /...published in the October. 26 issue of the Clinical...phrology, indicates though many people are of the ...
...of hay fever and eczema in the U.K has steadied co...isen sharply.// In the research that has been pub...scientists at the University of Edinburgh have sai...ver in UK have stabilised, after many years of ste...
...e an increased risk of developing lymphoma and leu...auses a lot of joint pain does have the risk of ca...rugs (DMARDs) – including tumor necrosis factor al...logic DMARD may play a role in this. TNF blockers...
Other Medicine News:Health News:Doctors worried about Homeopathic licensing 2Health News:A Glass of Orange Juice To Keep Recurrence Of Kidney Stones At Bay 2Health News:Eczema And Hay Fever Decline In UK While Allergic Reactions On The Rise 2Health News:RA Drugs Not Implicated In Cancer 2
(Date:10/8/2008)...tments for Spinal Cord, Other Nerve,Injuries -, P...rotein that enables,nerve cells to communicate wit...eveloping nervous system. Research into how that p...ve cells may provide a basis for eventual,treatmen...us system,including spinal cord injury., "This e...
(Date:10/8/2008)...ts Expand Testing Using Cellular ... Oct. 8 /- Wild Blueberry antioxidant...ts from a new study,showing Wild Blueberries outpe...e apples, bananas, red grapes and strawberries in ...tivity (CAA) assay. New research,published in the ...
(Date:10/8/2008)...-- Vical Incorporated (Nasdaq: VICL ),today is pr...l data,demonstrating that the company,s Vaxfectin(...protein-based infectious disease vaccines and,pept....D., Ph.D., Vical,s,Senior Vice President of Produ...sday, October 8, at the World Vaccine Congress (Ly...
(Date:10/7/2008)...-- McLaren Health Care and its Great,Lakes Cancer ...g medical,minds to share the latest work underway ...ncer treatments. The October 11th symposium, hoste...Sukamal Saha, M.D., an,award-winning surgical onco...orectal cancer has gained worldwide recognition an...
Breaking Medicine Technology:Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2Louis Drapeau Joins Bionovos Board of Directors 3974 1Louis Drapeau Joins Bionovos Board of Directors 3974 2Louis Drapeau Joins Bionovos Board of Directors 3974 3Isolagen Inc Promotes Todd Greenspan to Chief Financial Officer 28CFO 29 14386 1Isolagen Inc Promotes Todd Greenspan to Chief Financial Officer 28CFO 29 14386 2Isolagen Inc Promotes Todd Greenspan to Chief Financial Officer 28CFO 29 14386 3Isolagen Inc Promotes Todd Greenspan to Chief Financial Officer 28CFO 29 14386 4STERIS Corporation Names Michael J Tokich Chief Financial Officer 14384 1STERIS Corporation Names Michael J Tokich Chief Financial Officer 14384 2STERIS Corporation Names Michael J Tokich Chief Financial Officer 14384 3STERIS Corporation Names Michael J Tokich Chief Financial Officer 14384 4VaxGen Common Stock Now Quoted on OTC Bulletin Board 3971 1VaxGen Common Stock Now Quoted on OTC Bulletin Board 3971 2VaxGen Common Stock Now Quoted on OTC Bulletin Board 3971 3VaxGen Common Stock Now Quoted on OTC Bulletin Board 3971 4
...f.--(BUSINESS WIRE)--Jul 6, 2007 - Cobalis Corp.,(...specializing in,anti-allergy medications, today re... III clinical trials for its drug,PreHistin(TM) in...nal allergic rhinitis, commonly known as hay fever...h placebo and,PreHistin-treated patient groups, th...
...pective biomarker trial in non-small cell lung can...tCall/ -- Response,Genetics, Inc. today announced ... the July 1 issue of the Journal of Clinical,Oncol...Excision-Repair Cross-Complementing 1 (ERCC-1) in ... cancer (NSCLC) predicts for,sensitivity to cispla...
Other Medicine Technology:Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 2Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 3Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 4Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 5Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 2Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 3Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 4
... surgical gloves were designed with the surgeon in... barrier protection, and value. It offers comfort ...e broader, anatomical design allows for an excelle...tivity and an effective grip, wet or dry. Beaded c...
The Next Generation in Operating Room Equipment and Management Solutions is here Today. NuBoom is a self-contained, pedestal-mounted boom that houses medical, audio and visual equipment.
...versatility and positioning, look to BERCHTOLD's O...design and 770 lb. weight capacity ensures configu... and patient sizes. The radiolucent phenolic table... accessed with a C-arm. An intuitive remote contro...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z37,158-0) or contact custom
Medicine Products: